The Challenge of High Cost Drugs in Specialty Pharmacy

Michael Zeglinski, vice president of Specialty Pharmacy Operations at BriovaRx, discusses how expensive hepatitis C drugs have impacted the specialty landscape.

Michael Zeglinski, vice president of Specialty Pharmacy Operations at BriovaRx, discusses how expensive hepatitis C drugs have impacted the specialty landscape.

Related Content:

InterviewsHepatitisSpecialty Pharmacy
Establishing Workflow for In-clinic, Home Administration of Cabotegravir-rilpivirine Injections for HIV-1
Data Points Show Value in Oncology Pharmacy
Updates in Prevention, Treatment of Cytokine Release Syndrome, Neurologic Toxicities for Patients With Multiple Myeloma